Stay updated on TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A new Revision: v3.6.3 entry has been added to the history and the previous Revision: v3.6.2 entry has been removed, representing an updated software version tag in the record history.
    Difference
    0.0%
    Check dated 2026-07-04T05:20:00.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The record update shows the study has completed and has a refreshed revision, replacing the previous Active, not recruiting status as part of the update.
    Difference
    0.4%
    Check dated 2026-06-27T03:08:15.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The study record now indicates that no participants are being sought, signaling that recruitment for this trial has ended. The record has been updated to Revision: v3.6.0, replacing the previous Revision: v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-12T16:46:26.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.5.5 as the latest entry, and the previous Revision: v3.5.4 is no longer listed.
    Difference
    0.1%
    Check dated 2026-06-05T17:12:53.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The history shows a new revision v3.5.4 added and the previous revision v3.5.3 removed, indicating the study record has been refreshed to the latest version.
    Difference
    0.1%
    Check dated 2026-05-15T05:53:27.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A site release/version label on the page footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a platform change rather than an update to the trial’s record history.
    Difference
    0.1%
    Check dated 2026-04-24T05:44:18.000Z thumbnail image

Stay in the know with updates to TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.